Cas:887593-56-8 tert-butyl 3-(3-bromophenyl)sulfonylazetidine-1-carboxylate manufacturer & supplier

We serve Chemical Name:tert-butyl 3-(3-bromophenyl)sulfonylazetidine-1-carboxylate CAS:887593-56-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-butyl 3-(3-bromophenyl)sulfonylazetidine-1-carboxylate

Chemical Name:tert-butyl 3-(3-bromophenyl)sulfonylazetidine-1-carboxylate
CAS.NO:887593-56-8
Synonyms:tert-butyl 3-(3-bromophenyl)sulfonylazetidine-1-carboxylate
Molecular Formula:C14H18BrNO4S
Molecular Weight:376.26600
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:72.06000
Exact Mass:375.01400
LogP:3.86080

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like tert-butyl 3-(3-bromophenyl)sulfonylazetidine-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl 3-(3-bromophenyl)sulfonylazetidine-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-butyl 3-(3-bromophenyl)sulfonylazetidine-1-carboxylate Use and application,tert-butyl 3-(3-bromophenyl)sulfonylazetidine-1-carboxylate technical grade,usp/ep/jp grade.


Related News: Throughout the pandemic, our site remained fully operational while keeping our employees safe and having a positive impact on human health. Our expanded facility will provide us with the increased capacity needed to continue the essential services we provide to our clients” 3-(2-Fluoro-3-methylphenyl)propanal manufacturers Results from a Phase I clinical trial, published in The Lancet, found that two-doses of the inhaled Ad5-nCoV vaccine can trigger a similar immune response to a single-dose of the injected version. [2-chloro-3,5-difluoro-4-(trifluoromethyl)phenyl]hydrazine suppliers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” Acetic acid, polymer with chloroethene vendor & factory.